Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿ø¹ß¼º°£¼¼Æ÷¾ÏÀÇ Áø´Ü¿¡ À־ÀÇ Ç÷û Ferritin ÃøÁ¤ÀÇ ÀÇÀÇ Clinical Significance of Serum Ferritin Determination in the Diagnosis of Primary Hepatocellular Carcinoma

´ëÇѾÏÇÐȸÁö 1986³â 18±Ç 1È£ p.29 ~ 34
¼Ò¼Ó »ó¼¼Á¤º¸
À¯ÀçÈ­/Ryu, Jae Hwa ¾ç»óÈ£/¹Ú¿äÇÑ/±¸ÀÚ¿µ/¹Úº´Ã¤/Yang, Sang Ho/Park, Yo Han/Koo, Ja Young/Park, Byung Chae

Abstract


In an attempt to verify the possibility that serum ferritin and serum ferritin/transaminases ratio might be an useful marker in the diagnosis of primary hepatocellular carcinoma, we checked serum ferritin level as well as serum ferritin/transaminases ratio in 52 patients with chronic liver diseases including primary hepatocellular carcinoma.
Serum ferritin level in patients with liver cirrhosis (281¡¾4.83§¶/L, mean¡¾SE) and with hepatocellular carcinoma(321¡¾29.73 §¶/L, mean¡¾SE) were significantly(p<0.0005) elevated in comparison to normal control group(78.33¡¾4.24 §¶/L, mean¡¾SE), but no statistical significance was observed between the patient groups of liver cirrhosis and hepatocellular carcinoma.
Moreover, we also failed to observe. a significant difference of serum ferritin/transaminases ratio in patients with liver cirrhosis (8.30¡¾1.63, mean¡¾SE) and with hepatocellular carcinoma(8.46¡¾1.62, mean¡¾SE).
The results of this study, therefore, would indicate that serum . ferritin determination seems to be not helful in the differential diagnosis of primary hepatocellular carcinoma.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS